ipamorelin + cjc 1295 dac CJC-1295 No 10mg CJC-1295 No DAC + Ipamorelin

One 8-week study (n = 13) found a large effect size (d = 1.616) in reducing repetitive behaviors, as measured by the C-YBOCS (185), while a 12-week trial (n = 27) showed significant improvement in irritability on the Aberrant Behavior Checklist-Irritability subscale and Clinical Global Impression-Improvement scale (186)

Notably, a few compounds remained cytotoxic at the lower concentration (10 M)

Juste et al., 2021) (Figure 3)

Host metabolic reprogramming in response to SARS-CoV-2 infection: a systems biology approach

The percentage inhibition of RONS was calculated based on the ratio of fluorescent intensity and the number of detected cells between treated and untreated samples 43,44